IT1116524B - Procedimento di preparazione e composizione per la prevenzione ed il trattamento dell'artrite reumatoide e simili - Google Patents

Procedimento di preparazione e composizione per la prevenzione ed il trattamento dell'artrite reumatoide e simili

Info

Publication number
IT1116524B
IT1116524B IT47888/79A IT4788879A IT1116524B IT 1116524 B IT1116524 B IT 1116524B IT 47888/79 A IT47888/79 A IT 47888/79A IT 4788879 A IT4788879 A IT 4788879A IT 1116524 B IT1116524 B IT 1116524B
Authority
IT
Italy
Prior art keywords
prevention
preparation
treatment
similar
rheumatoid arthritis
Prior art date
Application number
IT47888/79A
Other languages
English (en)
Italian (it)
Other versions
IT7947888A0 (it
Original Assignee
Stolle Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stolle Res & Dev filed Critical Stolle Res & Dev
Publication of IT7947888A0 publication Critical patent/IT7947888A0/it
Application granted granted Critical
Publication of IT1116524B publication Critical patent/IT1116524B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0266—Klebsiella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0283—Shigella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IT47888/79A 1978-02-06 1979-02-05 Procedimento di preparazione e composizione per la prevenzione ed il trattamento dell'artrite reumatoide e simili IT1116524B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87514078A 1978-02-06 1978-02-06

Publications (2)

Publication Number Publication Date
IT7947888A0 IT7947888A0 (it) 1979-02-05
IT1116524B true IT1116524B (it) 1986-02-10

Family

ID=25365266

Family Applications (1)

Application Number Title Priority Date Filing Date
IT47888/79A IT1116524B (it) 1978-02-06 1979-02-05 Procedimento di preparazione e composizione per la prevenzione ed il trattamento dell'artrite reumatoide e simili

Country Status (10)

Country Link
JP (1) JPS54113425A (cg-RX-API-DMAC10.html)
CH (1) CH651210A5 (cg-RX-API-DMAC10.html)
DE (1) DE2904044C2 (cg-RX-API-DMAC10.html)
DK (1) DK158138C (cg-RX-API-DMAC10.html)
FR (1) FR2416015A1 (cg-RX-API-DMAC10.html)
GB (1) GB2013691B (cg-RX-API-DMAC10.html)
HK (1) HK30283A (cg-RX-API-DMAC10.html)
IT (1) IT1116524B (cg-RX-API-DMAC10.html)
NL (1) NL7900766A (cg-RX-API-DMAC10.html)
SE (1) SE448344B (cg-RX-API-DMAC10.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE33565E (en) * 1978-02-06 1991-04-02 Stolle Research And Development Corporation Prevention and treatment of rheumatioid arthritis
US4732757A (en) * 1978-02-06 1988-03-22 Stolle Research And Development Corporation Prevention and treatment of rheumatoid arthritis
DE3264713D1 (en) * 1981-02-26 1985-08-22 Unilever Plc A process and apparatus for the recovery of immunoglobulines
DE3172807D1 (en) * 1981-04-28 1985-12-12 Stolle Res & Dev Method of obtaining an anti-inflammatory bovine milk
JP2561234B2 (ja) * 1981-05-12 1996-12-04 スト−ル・リサ−チ・アンド・デイベロップメント・コ−ポレ−ション 抗炎症剤
JPS58154513A (ja) * 1982-03-09 1983-09-14 Sendai Biseibutsu Kenkyusho 予防及び治療薬
US4636384A (en) * 1982-06-03 1987-01-13 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
DE3378890D1 (en) * 1983-06-07 1989-02-16 Stolle Res & Dev Deodorant containing bacterial antibodies
JPS6112629A (ja) * 1984-06-28 1986-01-21 Lion Corp 口腔内組成物
EP0300102B1 (en) * 1987-07-21 1993-03-24 The Stolle Research And Development Corporation Improved method of obtaining immune regulatory factors by mammal immunization
JP2664906B2 (ja) * 1987-08-13 1997-10-22 ストール・リサーチ・アンド・デイベロップメント・コーポレーション 改良された哺乳類の免疫法
EP1171161A1 (en) * 1999-04-19 2002-01-16 Richard Weisbart Treatment of adult rheumatoid arthritis by oral administration of pooled human immunoglobulin and an antacid
EP1341552A2 (en) * 2000-09-28 2003-09-10 Research Corporation Technologies, Inc Treatment of immune-mediated diseases by oral administration of plasma fractions
AU2002309486A1 (en) * 2001-01-30 2002-10-15 The Lauridsen Group, Incorporated Methods and compositions for modulating the immune system of animals
PL211753B1 (pl) * 2001-01-30 2012-06-29 Lauridsen Group Zastosowanie koncentratu antygenowo nie-specyficznych immunoglobulin pochodzących z krwi zwierząt i kompozycja farmaceutyczna zawierająca immunoglobuliny
JP4960632B2 (ja) * 2006-01-10 2012-06-27 学校法人北里研究所 免疫ミルク組成物を有効成分とする単純ヘルペスウイルス感染症治療予防用組成物
JP5361132B2 (ja) * 2006-03-10 2013-12-04 国立大学法人信州大学 免疫グロブリンｇを含有する経口用免疫調節剤、その製造方法及び経口用免疫調節剤を配合してなる飲食品
JP2008179572A (ja) * 2007-01-25 2008-08-07 Shinshu Univ 免疫グロブリンＦｃフラグメントレセプタータンパク及び／又は免疫グロブリンＦｃフラグメントレセプター様タンパク産生抑制剤及びその使用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5136326B1 (cg-RX-API-DMAC10.html) * 1965-10-24 1976-10-07
DE1617769A1 (de) * 1967-06-10 1971-04-01 Rehm Eberhard Verfahren zur Gewinnung von spezifischen Antikoerper enthaltender Milch und daraus hergestellter Praeparate
JPS5136326A (ja) * 1974-09-24 1976-03-27 Komatsu Seiren Co Seikeigorufubooru
JPS5837285B2 (ja) * 1975-05-29 1983-08-15 カブシキガイシヤ ミドリジユウジ チヨウナイカンセンシヨウチリヨウザイノセイゾウホウホウ
JPS521014A (en) * 1975-06-17 1977-01-06 Stolle Res & Dev Pharmaceutically acceptable carrier containing milk immunoglobulin
JPS5381613A (en) * 1976-12-28 1978-07-19 Green Cross Corp:The Remedies for enteral infection diseases
CH627079A5 (en) * 1977-04-15 1981-12-31 Nestle Sa Process for preparing a protein concentrate containing immunological factors of milk origin

Also Published As

Publication number Publication date
JPS54113425A (en) 1979-09-05
DK158138C (da) 1990-08-27
DE2904044C2 (de) 1986-02-06
SE448344B (sv) 1987-02-16
FR2416015A1 (fr) 1979-08-31
DK158138B (da) 1990-04-02
GB2013691A (en) 1979-08-15
GB2013691B (en) 1982-08-18
CH651210A5 (de) 1985-09-13
HK30283A (en) 1983-09-02
DK49479A (da) 1979-08-07
JPH0160455B2 (cg-RX-API-DMAC10.html) 1989-12-22
SE7900798L (sv) 1979-08-07
IT7947888A0 (it) 1979-02-05
FR2416015B1 (cg-RX-API-DMAC10.html) 1983-06-17
DE2904044A1 (de) 1979-08-30
NL7900766A (nl) 1979-08-08

Similar Documents

Publication Publication Date Title
IT7947888A0 (it) Procedimento di preparazione e composizione per la prevenzione ed il trattamento dell'artrite reumatoide e simili
IT1113314B (it) Procedimento di sintesi dell'ammoniaca
IT1171339B (it) Composti inibitori dell'enzima aromatasi e procedimento per la loro preparazione
IT1147821B (it) Composizione per il trattamento o la prevenzione di stati infiammatoti dell'intestino nei mammiferi e procedimento di preparazione
IT8320435A0 (it) Composizione per il trattamento dell'acne.
IT8419141A0 (it) Procedimento per la preparazione dell'estere metilico di alfa-l-aspartil-l-fenilalanina.
IT1184194B (it) Trasmettitore elettrico dell'angolo di rotazione
IT8421342A0 (it) Composizioni e composti per il trattamento dell'adenoma prostatico.
IT1098416B (it) Procedimento per la produzione di laterizi ed impianto per l'attuazione di detto procedimemto
IT1125604B (it) Procedimento per la preparazione di n-fenil-n'-alchilfenilendiammine
IT1096665B (it) Composizione farmaceutica per la terapia di stati di frigidita' ed impotenza
IT1124845B (it) Metodo per regolare l'altezza di blocchi da costruzione e simili e dispositivo per attuare detto metodo
IT8149979A0 (it) Procedimento per la produzione dell'ormone paratiroideo umano
IT8520463A0 (it) Trattamento dell'osteoporosi.
IT8321080A0 (it) Procedimento per la preparazione dell'estere metilico di alfa-l-aspartil-l-fenil-alanina.
IT1110294B (it) Procedimento per la preparazione dell'isoforone incolore e stabile
IT8520448A0 (it) Trattamento dell'osteoporosi.
IT8467183A1 (it) Composizione farmaceutica per la profilassi ed il trattamento dell'arteriosclerosi.
IT1145433B (it) Composizione farmaceutiche impiegabili per il trattamento dell'ipertensione
IT1148788B (it) Derivati dell'amminoisochinolina e procedimento per la loro preparazione
IT1122095B (it) Metodo per la terapia dell'artrite reumatoide e formulazioni farmaceutiche idonee allo scopo
IT1155457B (it) Procedimento per l apreparazione di derivati dell'ossadiazolidina
IT1147314B (it) Nuovi medicamenti per il trattamento dell'obesita'
IT1135094B (it) Procedimento per la preparazione dell'l-5-idrossitriptofano
IT1141050B (it) Procedimento per la preparazione dell'amiodarone

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19980225